Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy

被引:2
作者
Lass-Floerl, Cornelia [1 ]
机构
[1] Dept Hyg Microbiol & Social Med, A-6020 Innsbruck, Austria
关键词
antifungal treatment; Aspergillus infections; Candida infections; children; fungal infections; pediatric; LIPOSOMAL AMPHOTERICIN-B; CLINICAL-PRACTICE GUIDELINES; NOSOCOMIAL INFECTIONS; DISEASES SOCIETY; ASPERGILLOSIS; CASPOFUNGIN; CANDIDEMIA; MICAFUNGIN; VORICONAZOLE; SAFETY;
D O I
10.1586/ERI.09.128
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Invasive fungal infections in children appear to have increased over the past few decades. Substantial differences compared with adult patients in risk factors, pathogen epidemiology, pathophysiology and, most notably, pharmacokinetics of antifungal agents require age-adapted management and treatment approaches. The present article reviews these aspects for invasive aspergillosis and invasive candidiasis, the two most common life-threatening fungal infections.
引用
收藏
页码:127 / 135
页数:9
相关论文
共 64 条
[1]   Invasive aspergillosis in primary immunodeficiencies [J].
Almyroudis, NG ;
Holland, SM ;
Segal, BH .
MEDICAL MYCOLOGY, 2005, 43 :S247-S259
[2]   Fungal infections in primary immunodeficiencies [J].
Antachopoulos, Charalampos ;
Walsh, Thomas J. ;
Roilides, Emmanuel .
EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (11) :1099-1117
[3]   Micafungin in pediatrics: when one size does not fit all [J].
Ashouri, Negar ;
Singh, Jasjit ;
Arrieta, Antonio .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (04) :463-469
[4]   Combination antifungal therapy for the treatment of invasive yeast and mold infections [J].
Baddley J.W. ;
Pappas P.G. .
Current Infectious Disease Reports, 2007, 9 (6) :448-456
[5]   Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections [J].
Benjamin, DK ;
Driscoll, T ;
Seibel, NL ;
Gonzalez, CE ;
Roden, MM ;
Kilaru, R ;
Clark, K ;
Dowell, JA ;
Schranz, J ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :632-638
[6]   Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients [J].
Blyth, Christopher C. ;
Chen, Sharon C. A. ;
Slavin, Monica A. ;
Serena, Carol ;
Nguyen, Quoc ;
Marriott, Deborah ;
Ellis, David ;
Meyer, Wieland ;
Sorrell, Tania C. .
PEDIATRICS, 2009, 123 (05) :1360-1368
[7]   Treatment of invasive fungal infections in cancer patients-Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) [J].
Boehme, Angelika ;
Ruhnke, Markus ;
Buchheidt, Dieter ;
Cornely, Oliver A. ;
Einsele, Herrmann ;
Enzensberger, Ruxandra ;
Hebart, Holger ;
Heinz, Werner ;
Junghanss, Christian ;
Karthaus, Meinolf ;
Kruger, William ;
Krug, Utz ;
Kubin, Thomas ;
Penack, Olaf ;
Reichert, Dietmar ;
Reuter, Stefan ;
Silling, Gerda ;
Sudhoff, Thomas ;
Ullmann, Andrew J. ;
Maschmeyer, Georg .
ANNALS OF HEMATOLOGY, 2009, 88 (02) :CP6-110
[8]   Pediatric invasive aspergillosis: A multicenter retrospective analysis of 139 contemporary cases [J].
Burgos, Ana ;
Zaoutis, Theoklis E. ;
Dvorak, Christopher C. ;
Hoffman, Jill A. ;
Knapp, Katherine M. ;
Nania, Joseph J. ;
Prasad, Priya ;
Steinbach, William J. .
PEDIATRICS, 2008, 121 (05) :E1286-E1294
[9]   Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients [J].
Cesaro, Simone ;
Giacchino, Mareva ;
Locatelli, Franco ;
Spiller, Monica ;
Buldini, Barbara ;
Castellini, Claudia ;
Caselli, Desiree ;
Giraldi, Eugenia ;
Tucci, Fabio ;
Tridello, Gloria ;
Rossi, Mario Renato ;
Castagnola, Elio .
BMC INFECTIOUS DISEASES, 2007, 7 (1)
[10]  
*CLIN GOV, AN PLUS VOR VERS VOR